Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
Live: FICCI live: Gadkari on future of mobility
Budget 2023
Budget 2023
you are here: HomeNewscoronavirus

Hype or hope? Oxford COVID-19 vaccine trial data is expected today — what we know so far

The data will be published in British peer-reviewed medical journal the Lancet.

July 20, 2020 / 10:45 PM IST

The early-stage human trial data of the COVID-19 vaccine that has been developed in a joint collaboration between Oxford University and British-Swedish drugmaker AstraZeneca will be released on July 20.

The data, which has been widely anticipated, will be published in British peer-reviewed medical journal the Lancet. The Oxford vaccine, also known as ChAdOx1 nCoV-19, was developed by the Jenner Institute and Oxford Vaccine Group, at the University of Oxford.

The vaccine uses a weakened version of chimpanzee adenovirus as a vector, infused with the genetic material of SARS-CoV-2 spike protein. 

Adenovirus is a benign virus that causes the common cold, and so the safety of the vaccine is assured. The Chimpanzee adenovirus is used to help circumvent the problem of pre-existing immunity encountered with other human adenovirus vectors.